# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-018688
Filing Date
2021-04-13
Accepted
2021-04-13 16:07:09
Documents
6
Period of Report
2021-05-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | fgen-def14a_20210526.htm | DEF 14A | 2268459
2 | GRAPHIC | gxkxeifxlup1000004.jpg | GRAPHIC | 637720
3 | GRAPHIC | gxkxeifxlup1000001.jpg | GRAPHIC | 35334
4 | GRAPHIC | gxkxeifxlup1000002.jpg | GRAPHIC | 14895
5 | GRAPHIC | gxkxeifxlup1000003.jpg | GRAPHIC | 13115
6 | GRAPHIC | gxkxeifxlup1000005.jpg | GRAPHIC | 228565
| Complete submission text file | 0001564590-21-018688.txt |  | 3549762

Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36740 | Film No.: 21823160
SIC: 2834 Pharmaceutical Preparations